Current insurance policies and treatment guidelines must evolve to accommodate this evidence-based approach
Side effects Commonly reported side effects of this medication include: Nausea Diarrhea Vomiting Stomach pain Constipation Gastrointestinal issues Bloating Other potential side effects: Indigestion Dizziness Back pain Increased lipase or amylase Altered taste Nasopharyngitis (common cold) Passing gas Bloating Belching Gastroenteritis Decreased appetite Gastroesophageal reflux disease Upset stomach These symptoms often subside as your body adjusts to the medications
This causes an increase in muscle mass and strength, as well as fat loss due to increased metabolism and lipolysis (the breakdown of fat)
It's important to note that individual responses may vary
Research using chicken chorioallantoic membrane (CAM) assays and endothelial tube formation assays demonstrates BPC-157 significantly increases vessel density both in vivo and in vitro
During your consultation, our medical team reviews your health history, current medications, and goals, and determines whether semaglutide or tirzepatide is a fit or whether another approach makes more sense